Menopausal obesity – myth or fact?

References

• Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med 1995;333:677–85
   PubMed Web of Science ®Google Scholar
• Ley CJ, Lees B, Stevenson JC. Sex- and meno-pause-associated changes in body fat distribu-tion. Am J Gun Nutr 1992;55:950–4
   Google Scholar
• Pasquali R, Casimirri F, Labate A, et al. Body weight, fat distribution and the menopausal status in women. Int J Obesity 1994;18:14–21
   Google Scholar
• Tremollieres FA, Poulles JM, Ribot CA. Rela-tive influence of age and menopause on total and regional body composition changes in postmenopausal women. Am J Obstet Gynecol 1996;175:1594–600
   Google Scholar
• Wang Q, Hassager C, Ravn P, et al. Total and regional body composition changes in early postmenopausal women: age related or meno-pause related? Am J Gun Nutr 1994;60:843–8
   PubMed Web of Science ®Google Scholar
• Aloia JF, Vaswani A, Ma R, et al. Aging in women — the four-compartment model of body composition. Metabolism 1996;45:43–8
   PubMed Web of Science ®Google Scholar
• Svendsen OL, Hassager C, Christiansen C. Age-and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry. Metabolism 1995;44:369–73
   Google Scholar
• Wing RR, Matthews KA, Kuller LH, et al. Weight gain at the time of the menopause. Arch Intern Med 1991;151:97–102
   PubMed Web of Science ®Google Scholar
• Kotani K, Tokunaga K, Fujioka S, et al. Sexual dimorphism of age related changes of whole body fat distribution in the obese. Int J Obesity Relat Metab Disord 1994;18:207–12
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Ciaponi M, Cappagli B, et al. Climacteric modifications in body weight and fat tissue distribution. Climacteric 1999;2: 37–44
   PubMedGoogle Scholar
• Guthrie JR, Dennerstein L, Dudley EC. Weight gain and the menopause: a 5-years prospective study. Climacteric 1999;2: 205–11
   Google Scholar
• Despres JP, Moorjani S, Lupien PJ, et al. Regional distribution of body fat, plasmalipoproteins, and cardiovascular disease. Arteriosclerosis 1990;10:497–511
   PubMedGoogle Scholar
• Silver AJ, Guilles CP, Kahl MJ, et al. Effect of aging on body fat. J Am Geriatr Soc 1993; 41:211–13
   PubMed Web of Science ®Google Scholar
• Kirchengast S, Gruber D, Sator M, et al. Postmenopausal weight status, body composi-tion and body fat distribution in relation to parameters of menstrual and reproductive history. Maturitas 1999;33:117–26
   PubMed Web of Science ®Google Scholar
• Troisi RJ, Wolf AM, Mason JE, et al. Relation of body fat distribution to reproductive factors in pre- and postmenopausal women. Obesity Res 1995;3:143–51
   PubMedGoogle Scholar
• Bray GA. Etiology and pathogenesis of obesity. Clin Cornerstone 1999;2:1–15
   PubMedGoogle Scholar
• Griffiths M, Payne PR, Stunkard AJ, et al. Metabolic rate and physical development in children at risk of obesity. Lancet 1990;336: 76–7
   PubMed Web of Science ®Google Scholar
• Ravussin E, Lillioja S, Knowler WC, et al. Reduced rate of energy expenditure as a risk factor for body weight gain. N Engl J Med 1988;318:467–72
   PubMed Web of Science ®Google Scholar
• Ravussin E, Lillioja S, Anderson TE, et al. Determinants of 24-hour energy expenditure in man. J Clin Invest 1986;78:1568–78
   PubMed Web of Science ®Google Scholar
• Shimokata H, Kuzuya F. Aging, basal metabolic rate, and nutrition. Nippon Ronen Igakkai Zasshi 1993;30:572–6
   PubMedGoogle Scholar
• Vaughan L, Zurlo F, Ravussin E. Aging and energy expenditure. Am J Clin Nutr 1991;53: 821–5
   PubMed Web of Science ®Google Scholar
• Piers LS, Soares MJ, McCormack LM, et al. Is there evidence for an age-related reduction in metabolic rate? J Appl Physiol 1998;85: 2196–204
   PubMed Web of Science ®Google Scholar
• Acheson KJ, Ravussin E, Schoeller DA, et al. Two-week stimulation or blockade of the sympathetic nervous system in man: influence on body weight, body composition, and twentyfour-hour energy expenditure. Metabolism 1988;37:91–8
   PubMed Web of Science ®Google Scholar
• Saad MF, Alger SA, Zurlo F, et al. Ethnic differ-ences in sympathetic nervous system-mediated energy expenditure. Am J Physiol 1991;261: E784–9
   Google Scholar
• Spraul M, Ravussin E, Fontvieille AM, et al. Reduced sympathetic nervous activity. A poten-tial mechanism predisposing to body weight gain. J Clin Invest 1993;92:1730–5
   Google Scholar
• Tataranni PA, Larson DE, Snitker S, et al. Thermic effect of food in humans: methods and results from use of respiratory chamber. Am J Clin Nutr 1995; 61:1013–1
   PubMed Web of Science ®Google Scholar
• Snitker S, Macdonald I, Ravussin E, et al. The sympathetic nervous system and obesity: role in aetiology and treatment. Obesity Rev 2000; 1:5–15
   PubMedGoogle Scholar
• Young JB, Macdonald IA. Sympathoadrenal activity in human obesity: heterogeneity and findings since 1980. Int J Obesity Relat Metab Disord 1992;16:959–67
   PubMed Web of Science ®Google Scholar
• Tataranni PA, Young JB, Bogardus C, et al. A low sympathetic nervous system activity is asso-ciated with body weight gain in Pima Indians. Obesity Res 1997;5:341–7
   PubMedGoogle Scholar
• Matsukawa T, Sugiyama Y, Watanabe T, et al. Gender difference in age-related changes in muscle sympathetic nerve activity in healthy subjects. Am J Physiol 1998;275:R1600–4
   PubMed Web of Science ®Google Scholar
• Jones PP, Davy KP, Alexander S, et al. Age-related increase in muscle sympathetic nerve activity is associated with abdominal adiposity. Am J Physiol 1997;272:E976–80
   PubMed Web of Science ®Google Scholar
• Sowers JR, Mohanty PK. Autonomic nervous system function. J Hypertens 1988;(Supp1)6: S4919654
   Google Scholar
• Poehlman ET, Toth MJ, Fonong T. Exercise, substrate utilisation and energy requirements in the elderly. Int J Obesity Relat Metab Disord 1995;19(Suppl 4):S93–6
   Google Scholar
• Supiano MA, Hogikyan RV, Sidani MA, et al. Sympathetic nervous system activity and a-adrenergic responsiveness in older hyper-tensive humans. Am J Physiol 1999;276: E519–28
   PubMed Web of Science ®Google Scholar
• Bouchard C, Perusse L, LeBlanc C, et al. Inheri-tance of the amount and distribution of human body fat. Int J Obesity Relat Metab Disord 1988;12:205–15
   PubMed Web of Science ®Google Scholar
• Rothwell NJ, Stock MJ. A role for brown adipose tissue in diet-induced thermogenesis. Nature (London) 1979;281:31–5
   PubMed Web of Science ®Google Scholar
• Lowell BB, Flier JS. Brown adipose tissue, j33-adrenergic receptors and obesity. Annu Rev Med 1997;48:307–16
   PubMed Web of Science ®Google Scholar
• Tchernof A, Starling RD, Walston JD, et al. Obesity-related phenotypes and the 133-adreno-ceptor gene variant in postmenopausal women. Diabetes 1999;48:1425–8
   PubMed Web of Science ®Google Scholar
• Garcia-Rubi E, Starling RD, Tchernof A, et al. Trp64Arg variant of the j33-adrenoceptor and insulin resistance in obese postmenopausal women. J Clin Endocrinol Metab 1998;83: 4002–5
   Google Scholar
• Walder K, Norman RA, Hanson RL, etal. Asso-ciation between uncoupling protein polymor-phisms (UCP2—UCP3) and energy metabolism/ obesity in Pima Indians. Hum Mol Genet 1998; 7:1431–5
   PubMed Web of Science ®Google Scholar
• Zhang Y, Porenca R, Mattei M, et al. Position-ing cloning of the mouse obese gene and its human homologue. Nature (London) 1994; 372:425–32
   PubMed Web of Science ®Google Scholar
• Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature (London) 1997;387:903–8
   PubMed Web of Science ®Google Scholar
• Clement K, Vaisse C, Lahlou N, et al. A muta-tion in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature (London) 1998;392:398–401
   PubMed Web of Science ®Google Scholar
• Ristow M, Muller-Wieland D, Pfeiffer A, et al. Obesity associated with a mutation in genetic regulator of adipocyte differentiation. N Engl J Med 1998;339:953–9
   PubMed Web of Science ®Google Scholar
• Spiegelman BM, Flier JS. Adipogenesis: round-ing out the big picture. Cell 1996;87:377–89
   PubMed Web of Science ®Google Scholar
• Deng FIW, Li J, Li JL, et al. Association of estro-gen receptor-a genotypes with body mass index in normal healthy postmenopausal Caucasian women. J Clin Endocrinol Metab 2000;85: 2748–51
   PubMed Web of Science ®Google Scholar
• Milewicz A, Bidziiiska B, Sidorowicz A. Pen-menopausal obesity. Gynecol Endocrinol 1996; 10:25–91
   Google Scholar
• Bray GA, Fisler JS, York DA. Neuroendocrine control of development of obesity: under-standing gained from studies of experimental animal models. Front Neuroendocrinol 1990; 11:128–81
   Google Scholar
• Morley J. Neuropeptide regulation of appetite and weight. Endocr Rev 1987;8:256–87
   PubMed Web of Science ®Google Scholar
• Leibowitz S. Brain monoamines and peptides: role in the control of eating behaviour. Fed P roc 1986;45:1396–403
   PubMedGoogle Scholar
• Campfield LA, Smith FJ, Guisez Y, et al. Recombinant mouse ob protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546–8
   PubMed Web of Science ®Google Scholar
• Rosenbaum M, Nicolson M, Hirsch J, et al. Effects of gender, body composition, andmenopause on plasma concentrations of leptin.J Gun Endocrinol Metab 1996;81:3424–7
   PubMed Web of Science ®Google Scholar
• Shimizu H, Shimomura Y, Nakanishi Y, et al. Estrogen increases in vivo leptin production in rats and human subjects. J Endocrinol 1997; 154:285–92
   PubMed Web of Science ®Google Scholar
• Dulawa S, Vanderweele D. Cholecystokinin and estradiol synergistically potentate satiety in rats. Peptides 1994;15:913–18
   PubMed Web of Science ®Google Scholar
• Milewicz A, Bidziiiska B, Mikulski E, et al. Influence of obesity and menopausal status on serum leptin, cholecystokinin, galanin and neuropeptide Y levels. Gynecol Endocrinol 2000;14:196–203
   PubMed Web of Science ®Google Scholar
• Milewicz A, Mikulski E, Bidziiiska B. Endo-genous/exogenous estrogens and satiety plus appetite stimulating peptides in women. In Aso T, Yanaihara T, Taketani Y, et al. eds. The 9th International Menopause Society World Con-gress on the Menopause. Yokohama (Japan). Bologna: Monduzzi Editore, 1999:147–51
   Google Scholar
• Girasole G, Jilka RL, Passeri DC, et al. 170-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Endocrinol Metab 1992;89:883–91
   Web of Science ®Google Scholar
• Straub RH, Hense HW, Andus T, et al. Hormone replecement therapy and interaction between serum interleukin-6 and body mass index in postmenopausal women: a population study. J Clin Endocrinol Metab 2000;85: 1340–4
   PubMed Web of Science ®Google Scholar
• Lamberts SW, van den Belt AW, van der Ley AJ. The endocrinology of aging. Science 1997;278: 419–24
   PubMed Web of Science ®Google Scholar
• Espeland MA, Stefanick ML, Kritz-SiversteinD, et al. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen/Progestin Interventions Study Investigators. J Clin Endo-crinol Metab 1997;82:1549–56
   Google Scholar
• Hassager C, Christiansen C. Estrogen/gestagen therapy changes soft tissue body composition in postmenopausal women. Metabolism 1989;38: 662–5
   PubMed Web of Science ®Google Scholar
• Den Tonkelaar I, Seidell JC, van Nord PHA, et al. Fat distribution in relation to age, degree of obesity, smoking habits, parity and estrogen use: a cross-sectional study in 11 824 Dutch women participating in the DOM-project. Int J Obesity 1990;14:753–61
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Ciaponi M, Cappag,li B, et al. Body weight, body fat distribution, and hor-monal replacement therapy in early postmeno-pausal women. J Clin Endocrinol Metab 1997; 82:414–17
   Google Scholar
• Heiss CJ, Sanborn CF, Nichols DL, et al. Associ-ation of body fat distribution, circulating sex hormones, and bone density in postmenopausal women. J Clin Endocrinol Metab 1995;80: 1591–6
   PubMed Web of Science ®Google Scholar
• Bjorntrop P. Endocrine abnormalities of obesity. Meta Clin Exp 1995;44:21–3
   PubMed Web of Science ®Google Scholar
• Bjorntrop P. The regulation of adipose tissue distribution in humans. Int J Obesity Relat Metab Disord 1996;20:291–302
   PubMed Web of Science ®Google Scholar
• Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obesity 1998;22:1145–58
   Google Scholar
• Rebuffe-Scrive M, Enk L, Crona N, et al. Fat cell metabolism in different regions in women. Effects of menstrual cycle, pregnancy and lacta-tion. J Clin Invest 1985;75:1973–6
   Google Scholar
• Xu X, Bjorntrop P. The effects of steroid hor-mones on adipocyte development. Int J Obesity 1990;14(Suppl 3):159–63
   PubMedGoogle Scholar
• Rebuffe-Scrive M, Lundholm K, Bjorntrop P. Glucocorticoid binding of human adipose tissue. Eur J Clin Invest 1985;15:267–71
   PubMed Web of Science ®Google Scholar
• Bjorntrop P. Human control of regional fat dis-tribution. Hum Reprod 1997;12(Suppl):S21–5
   Google Scholar
• Elbers J, Asscheman M, Seidell, et al. Long-term testosterone administration increases visceral fat in female-to-male transsexuals. J Clin Endo-crinol Metab 1997;82:2044–7
   PubMed Web of Science ®Google Scholar
• Lovejoy J, Bray G, Bourgeois M, et al. Exo-genous androgens influence body composition and regional body fat distribution in obese postmenopausal women — a clinical research centre study. J Clin Endocrinol Metab 1996; 81:2198–203
   PubMed Web of Science ®Google Scholar
• Celary MP. The role of DHEA in obesity. In Dehydroepiandrosterone. Berlin: Walter de Gruyter & Co, 1990:207–30
   Google Scholar
• Celary MP. The antiobesity effect of dehydro-epiandrosterone in rats. Proc Soc Exp Biol Med 1991;196:8–16
   PubMedGoogle Scholar
• Bernadier CD, Parente JA, McIntosch MK. Is dehydroepiandrosterone an antiobesity agent? FASEB J 1993;7:414–19
   PubMedGoogle Scholar
• Mac Ewen EG, Kurzman ID. Obesity in the dog: role of the adrenal steroid dehydroepiandro-sterone (DHEA). J Nutr 1991;121:S51–5
   PubMed Web of Science ®Google Scholar
• Coleman DL, Leiter EH, Schwizer RW. Thera-peutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 1982;31: 830–3
   PubMed Web of Science ®Google Scholar
• Berr C, Lafont S, Debuire B, et al. Relationship of dehydroepiandrosterone sulfate in elderly with functional psychological and mental status and short term mortality: a French community-based study. Proc Natl Acad Sci USA 1996;93: 13410–16
   PubMed Web of Science ®Google Scholar
• Orentreich N, Brind JL, Rizer RL, et al. Age changes and sex differences in serum dehydro-epiandrosterone sulphate content throughout adulthood. J Clin Endocrinol Metab 1984;59: 551–5
   PubMed Web of Science ®Google Scholar
• Lacroix AA, Yano K, Reed DM. Dehydro-epiandrosterone sulphate, incidence of myo-cardial infarction and extent of atherosclerosis in men. Circulation 1992;86:1529–35
   Google Scholar
• Nestler JE, Barlascini CO, Clore JN, et al. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat, but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 1988;66:57–61
   PubMed Web of Science ®Google Scholar
• Yen SSG, Morales AJ, Khorram 0. Replace-ment of DHEA in ageing men and women: potential remedial effects. In Bellino FL, Daynes RA, Hornsby PJ, et al., eds. D ehydroepiandro-sterone (DHEA) and Ageing. New York: New York Academy of Science, 1995:128–42
   Google Scholar
• Ghusn HF, Taffet G, Jaweed M, et al. DHEA improves lean body mass of older men. Presented at the 49th Annual Meeting of the American Gerontological Society Washington DC, 1996:abstr 69
   Google Scholar
• Diamond P, Cusan L, Gomez JL, et al. Meta-bolic effects of 12-months percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J Endocrinol 1996; 150:S43–50
   PubMed Web of Science ®Google Scholar
• Gansler TS, Miller S, Cleary MP. Chronic administration of dehydroepiandrosterone reduces pancreatic 0-cell hyperplasia and hyper-insulinemia in genetically obese Zucker rats. Proc Soc Exp Biol Med 1985;180: 155–62
   Google Scholar
• Morales AJ, Nolan JJ, Nelson JC, et al. Effects of replacement doses of dehydroepiandro-sterone in men and women of advancing age. J Clin Endocrinol Metab 1994;78:1360–7
   PubMed Web of Science ®Google Scholar
• Milewicz A, Jf drzejuk D, Bohdanowicz-Pawlak A, et al. Metabolic and hormonal changes after DHEA treatment. In Aso T, Yanaihara T, Taketani Y, et al., eds. The 9th International Menopause Society World Congress on the Menopause. Yokohama (Japan). Bologna: Monduzzi Editore, 1999:215–20
   Google Scholar
• Gertner JM. Effects of growth hormone on body fat in adults. Horm Res 1993;40:10–15
   PubMed Web of Science ®Google Scholar
• Abs R, Bengtsson BA, Hernberg-Stahl E, et al. GH replacement in 1034 growth hormone defi-cient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clin Endocrinol 1999;50: 703–13
   Google Scholar
• Hoffman DM, O'Sullivan AJ, Freund J, et al. Adults with growth hormone deficiency have abnormal body composition but normal energymetabolism. J Clin Endocrinol Metab 1995; 80:72–7
   PubMed Web of Science ®Google Scholar
• Bengtsson BA, Brummer RJ, Eden S, et al. Effects of growth hormone on fat mass and fat distribution. Acta Paediatr 1992;383 ( Suppl): 62–5
   Google Scholar
• Carroll PV, Christ ER, Bengtsson BA, et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. J Clin Endocrinol Metab 1998;83: 382–95
   PubMed Web of Science ®Google Scholar
• Salomon F, Cuneo RC, Hesp R, et al. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989;321:1797–803
   PubMed Web of Science ®Google Scholar
• Velasco B, Cacicedo L, Escalada J, etal. Growth hormone gene expression and secretion in ageing rats is age dependent and not age-associated weight increase related. Endocrino-logy 1998;139:1314–20
   PubMed Web of Science ®Google Scholar
• Iranmanesh A, Lizarralde G, Veldhuis JD. Age and related adiposity are specific negative deter-minants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 1991;73:1081–8
   Google Scholar
• Weltman A, Weltman JY, Abbott RD, et al. Relationship between age, percentage body fat, fitness and 24-hour growth hormone release in healthy young adults: effects of gender. J Clin Endocrinol Metab 1994;78:543–8
   PubMed Web of Science ®Google Scholar
• Tanaka K, Inoue S, Shiraki J, et al. Age-related decrease in plasma growth hormone: response to growth hormone-releasing hormone, arginine, and L-dopa in obesity. Metabolism 1991;40:1257–62
   PubMed Web of Science ®Google Scholar
• Hammerman MR. Insulin-like growth factors and ageing. Endocrinol Metab Clin 1987;16: 995–1011
   Web of Science ®Google Scholar
• Canalis E. Skeletal growth factors and ageing. J Clin Endocrinol Metab 1994;78:1009–10
   PubMed Web of Science ®Google Scholar
• Mann GV. The influence of obesity on health. N Engl J Med 1974;291:178–85
   PubMed Web of Science ®Google Scholar
• Van Itallie TB. Obesity: adverse effects on health and longevity. Am J Clin Nutr 1979;32 (Suppl):2723–33
   Google Scholar
• Lew EA, Garfinkel L. Variations in mortality by weight among 750 000 men and women. J Chron Dis 1979;32:563–76
   PubMedGoogle Scholar
• O'Doherty RO, Stein D, Foley J. Insulin resis-tance. Diabetologia 1997;40:B10–15
   PubMedGoogle Scholar
• Bjorntrop P. Abdominal obesity and the development of non-insulin dependent diabetes mellitus. Diabetes Metab Rev 1988;4:615–22
   PubMed Web of Science ®Google Scholar
• Kissebah AH, Peiris AN. Biology of regional body fat distribution: relationship tonon-insulin dependent diabetes mellitus. Diabetes Metab Rev 1989;5:83–109
   PubMed Web of Science ®Google Scholar
• Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595–67
   PubMed Web of Science ®Google Scholar
• Hubert HB, Fenileb M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation 1983;67:968–77
   PubMed Web of Science ®Google Scholar
• Larsson B, Svardsudd K, Welin L. et al. Abdom-inal adipose tissue distribution, obesity and risk of cardiovascular disease and death: 13-year follow-up of participants in the study of men born in 1913. Br Med J 1984;288: 1401–4
   Google Scholar
• Lapidus L, Bentgsson C, Larsson B, et al. Distri-bution of adipose tissue and risk of cardio-vascular disease and death: a 12 year follow-up of participants in the population study of women in Gothenburg, Sweden. Br Med J1984; 289:1257–61
   PubMed Web of Science ®Google Scholar
• Bjorntrop P. Obesity and risk of cardiovascular disease. Ann Clin Res 1985;17:3–9
   Google Scholar
• World Health Organization. The World Health Report 1999: Making a Difference. Geneva: WHO, 1999
   Google Scholar
• Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from Lipid Research Clinics Program Follow-up Study. Circulation 1987;75:1102–9
   PubMed Web of Science ®Google Scholar
• Crook D, Cust MP, Gangar KF, et al. Compari-son of transdermal and oral estrogen/progestin hormone replacement therapy: effect on serum lipids and lipoproteins. Am J Obstet Gynecol 1992;166:950–5
   PubMed Web of Science ®Google Scholar
• Walsh BW, Schiff I, Rosner B, et al. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of lipoproteins. N Engl J Med 1991;325:1196–204
   PubMed Web of Science ®Google Scholar
• Lobo RA. Effects of hormone replacement on lipids and lipoproteins in postmenopausal women. J Clin Endocrinol Metab 1991;73:925
   PubMed Web of Science ®Google Scholar
• Hanggi W, Lippuner K, Riesen W, et al. Long-term influence of different hormone replace-ment regiments on serum lipids and lipo-protein(a): a randomised study. Br J Obstet Gynaecol 1997;104:708–17
   PubMedGoogle Scholar
• Bjorkelund C, Lissner L, Andersson S, et al. Reproductive history in relation to relativeweight and fat distribution. Int J Obesity Relat Metab Disord 1996;20:213–19
   PubMed Web of Science ®Google Scholar
• Tchernof A, Poehlman ET, Despres JP. Body fat distribution, the menopause transition, and hormone replacement therapy. Diabetes Metab 2000;26:12–20
   Google Scholar
• Kritz-Silverstein D, Barrett-Connor E. Long-term postmenopausal hormone use, obesity, and fat distribution in older women. J Am Med Assoc. 1996;275:46–9
   PubMed Web of Science ®Google Scholar
• Speroff L, Rowan J, Symons J, et al. The com-parative effect on bone density, endometrium, and lipids of continuous hormones as replace-ment therapy (CHART study). A randomized controlled trial. J Am Med Assoc 1996;276: 1397–403
   PubMed Web of Science ®Google Scholar
• Aloia JF, Vaswani A, Russo L, et al. The influ-ence of menopause and hormonal replacement therapy on body cell mass and body fat mass. Am J Obstet Gynecol 1995;172:896–900
   PubMed Web of Science ®Google Scholar
• Haarbo J, Marslew U, Gotfredsen A, et al. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991;40:1323–6
   PubMed Web of Science ®Google Scholar
• Norman RJ, Flight IH, Rees MC. Oestrogen and progestogen hormone replacement therapy for pen-menopausal and post-menopausal women: weight and body fat distribution. Cochrane Database Syst Rev 2000;2: CD001018
   Google Scholar
• Chmouliovsky L, Habicht F, James RW, et al. Beneficial effect of hormone replacement therapy on weight loss in obese menopausal women. Maturitas 1999;32:147–53
   PubMed Web of Science ®Google Scholar
• Crawford SL, Casey VA, Avis NE, et al. A longi-tudinal study of weight and the menopause transition: results from the Massachusetts Women's Health Study. Menopause 2000;7: 96–104
   PubMed Web of Science ®Google Scholar
• Simkin-Silverman L, Wing RR, Hansen DH, et al. Prevention of cardiovascular risk factor elevations in healthy premenopausal women. Prey Med 1995;24:509–17
   Google Scholar
• Simkin-Silverman L, Wing RR, Boraz MA, et al. Maintenance of cardiovascular risk factor changes among middle-aged women in a life-style intervention trial. Women's Health 1998; 4:255–71
   Google Scholar